| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/11/2007 | EP1140907B1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | CN1997641A Diarylamine derivatives as calcium channel blockers |
| 07/11/2007 | CN1997640A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 07/11/2007 | CN1997628A Thio-substituted biaryl-methanesulfinyl derivatives |
| 07/11/2007 | CN1325492C Beta-isoindigo coloring agent |
| 07/11/2007 | CN1325489C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 07/11/2007 | CN1325475C Quinoline derivatives and their use as mycobacterial inhibitors |
| 07/11/2007 | CN1325472C Phenyl-substituted cyclic enaminones |
| 07/10/2007 | US7241891 Method for the purification of Piribedil |
| 07/10/2007 | US7241887 3-azabicyclo[3.2.1]octane derivatives |
| 07/10/2007 | US7241795 2,5-bis ((alkyl (or aryl) imino) aminophenyl) furans, thiophenes or pyrroles; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp., Pneumocystis carinii, Toxoplasma gondii, Fusarium solani, and Cryptococcus neoformans |
| 07/10/2007 | US7241760 Central nervous system disorders; psycholgical disorders; antiepi;eptic agents; schizophrenia; Alzheimer's disease; cognition activators; analgesics |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241757 Amidino derivatives and their use as thrombin inhibitors |
| 07/10/2007 | US7241745 Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives |
| 07/10/2007 | CA2466340C Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/05/2007 | WO2007076159A2 Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof |
| 07/05/2007 | WO2007076158A2 Processes for preparing darifenacin hydrobromide |
| 07/05/2007 | WO2007076157A2 Processes for preparing darifenacin hydrobromide |
| 07/05/2007 | WO2007076104A1 Vanilloid receptor ligands and their use in treatments |
| 07/05/2007 | WO2007074861A1 Optical recording medium and azacyanine dye |
| 07/05/2007 | WO2007074786A1 Probe for diagnosis of conformational disease |
| 07/05/2007 | WO2007074686A1 Method for producing optically active n-(3-halo-2-hydroxypropyl)phthalimide |
| 07/05/2007 | WO2007074364A1 Process for the preparation of alfuzosin |
| 07/05/2007 | WO2007074213A1 Macrocyclic oligonucleotide labeling reactants and conjugates derived thereof |
| 07/05/2007 | WO2007058602A3 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. |
| 07/05/2007 | WO2007058392A9 Heterocyclic compound and medicinal application thereof |
| 07/05/2007 | WO2007056596A3 Phosphoramidate derivatives of fau |
| 07/05/2007 | WO2007053765A3 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 07/05/2007 | WO2006064217A8 PROCESS FOR THE PREPARATION OF 4-(6-CHLORO-2, 3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-l-YL) ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE , THEIR INTERMEDIATES AND CRYSTALLINE SALTS THEREOF |
| 07/05/2007 | US20070155964 Naphthols useful for preparing indeno-fused photochromic naphthopyrans |
| 07/05/2007 | US20070155959 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 07/05/2007 | US20070155818 3-[5-ethoxy-1-(4-ethyl-benzenesulfonyl)-1H-indol-3-yl]-propionic acid for example; obesity, diabetes, syndrome X, breast or thyroid cancer, inflammatory skin disorders such as psoriasis, cardiovascular disorders, eating disorders such as bulimia; peroxisome proliferator-activated receptors (PPAR) agonist |
| 07/05/2007 | US20070155810 Enzyme inhibitors as bactericides for infections and enzyme inhibitors |
| 07/05/2007 | US20070155795 Muscarinic agonists |
| 07/05/2007 | US20070155793 4-(5-aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 07/05/2007 | US20070155792 Enzyme inhibitors as bactericides for infections and as enzyme inhibitors |
| 07/05/2007 | US20070155790 Meta-benzamidine derivatives as serine protease inhibitors |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155783 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155763 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the phophylaxis and treatment of disorders related thereto |
| 07/05/2007 | US20070155760 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155735 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 07/05/2007 | US20070155729 Therapeutic amine-arylsulfonamide conjugate compounds |
| 07/05/2007 | US20070155721 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide |
| 07/05/2007 | US20070155719 Platelet ADP receptor inhibitors |
| 07/05/2007 | US20070155712 Compounds for the inhibition of angiogenesis and use thereof |
| 07/05/2007 | US20070155701 Keto cannabinoids with therapeutic indications |
| 07/05/2007 | US20070155676 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 07/05/2007 | US20070152569 Novel benzo[b]furan derivatives and their use |
| 07/05/2007 | CA2633653A1 Heterocyclic derivatives as modulators of ion channels |
| 07/05/2007 | CA2631777A1 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor |
| 07/05/2007 | CA2630478A1 Processes for preparing darifenacin hydrobromide |
| 07/05/2007 | CA2626715A1 Processes for preparing darifenacin hydrobromide |
| 07/05/2007 | CA2625858A1 Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof |
| 07/04/2007 | EP1803719A1 1,5-diheterocycle-1h-triazole derivative |
| 07/04/2007 | EP1803709A1 Proton pump inhibitors |
| 07/04/2007 | EP1802615A1 Phosphodiesterase 4 inhibitors |
| 07/04/2007 | EP1802612A1 Novel b1 bradykinin receptor antagonists |
| 07/04/2007 | EP1802611A2 Heterocyclic diamide insecticidal agents |
| 07/04/2007 | EP1802610A1 Crystalline form 2 of atrasentan hydrochloride |
| 07/04/2007 | EP1802609A2 Thrombin receptor antagonists |
| 07/04/2007 | EP1802608A1 Quinazoline derivatives for use against cancer |
| 07/04/2007 | EP1802602A1 Substituted dipiperdine ccr2 antagonists |
| 07/04/2007 | EP1802590A1 Substituted n-alkylpyrimidinones |
| 07/04/2007 | EP1802588A1 Substituted amino-pyrimidones and uses thereof |
| 07/04/2007 | EP1802585A1 4-substituted 4,6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 07/04/2007 | EP1802572A1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 07/04/2007 | EP1644343B1 5-substituted quinazolinone derivatives |
| 07/04/2007 | EP1484971B1 Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces |
| 07/04/2007 | EP1260512B1 Novel cyclic amide derivatives |
| 07/04/2007 | EP1075473B1 Process for making 1,3-disubstituted-4-oxocyclic ureas |
| 07/04/2007 | EP0977750B1 Farnesyltransferase inhibiting quinazolinones |
| 07/04/2007 | CN1993368A Cci-779 derivatives and methods of making same |
| 07/04/2007 | CN1993359A Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 07/04/2007 | CN1993357A Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 07/04/2007 | CN1993353A Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 07/04/2007 | CN1993339A Aromatic compounds |
| 07/04/2007 | CN1993331A N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 07/04/2007 | CN1993329A Quinoline derivatives as neurokinin receptor antagonists |
| 07/04/2007 | CN1993325A Piperidine derivatives as histamine h3 receptor ligands |
| 07/04/2007 | CN1990486A N-glycyl-pyrrolidine-2-nitrile and its use as DDP-IV enzyme inhibitor |
| 07/04/2007 | CN1990477A Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/04/2007 | CN1990474A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 07/04/2007 | CN1990473A Tri-substituted 1H-imidazoles compounds, preparation method and pharmaceutical composition and pharmacy use thereof |
| 07/04/2007 | CN1990471A Mch antagonists and their use in the treatment of obesity |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1990452A Process to produce a protease inhibitor |
| 07/04/2007 | CN1324023C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 07/04/2007 | CN1324022C Inhibitors of tyrosine kinases |
| 07/04/2007 | CN1324015C Pyridine and pyrimidine derivatives |
| 07/04/2007 | CN1324014C Pyridazin-3(2h)-one derivatives as PDE4 inhibitors |
| 07/04/2007 | CN1324012C TNF-alpha prodn. inhibitors |
| 07/03/2007 | US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor |